Publications
Dr Psyrri has published more than 200 manuscripts in peer-reviewd journals
For more information please visit https://pubmed.ncbi.nlm.nih.gov/?term=psyrri&sort=date
Publications links
https://pubmed.ncbi.nlm.nih.gov/?term=psyrri
Can the standard chemotherapeutic regimen be improved upon for small-cell lung cancer?
A. Psyrri and G. Fountzilas: Can the standard chemotherapeutic regimen be improved upon for small-cell lung cancer? Commentary in Nature Clinical Practice Oncology, 2006 Jul; (7):360-1.
Evaluation of the Prognostic Value of C-Inhibitor of Apoptosis (cIAP) Protein in Epithelial Ovarian Cancer using Automated Quantitative Analysis (AQUA)
Psyrri, Z. Yu, A. Bamias, P.M. Weinberger, M. Kassar, S. Markakis, D. Kowalski, R.L. Camp, D.L. Rimm and M.A. Dimopoulos: Evaluation of the Prognostic Value of C-Inhibitor of Apoptosis (cIAP) Protein in Epithelial Ovarian Cancer using Automated Quantitative Analysis...
Subcellular Localization and Protein Levels of Cyclin-dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer
A. Psyrri, A. Bamias, Z. Yu, P.M. Weinberger, M. Kassar, S. Markakis, D. Kowalski, E. Efstathiou, R. L. Camp, D. L. Rimm and M.A. Dimopoulos: Subcellular Localization and Protein Levels of Cyclin-dependent Kinase Inhibitor p27 Independently Predict for Survival in...
Phase II trial of PFL-induction chemotherapy followed by concomitant cisplatin chemoradiotherapy (CRT) for head and neck squamous cell cancer (HNSCC)
*A. Psyrri, M. Kwong, L. Lekakis, M. Kassar , C. Sasaki, L. Wilson, B. Haffty, Y.H. Son, D.A. Ross, P. Weinberger, G. Chung, D. Zelterman, B.A. Burtness and D.L. Cooper; Phase II trial of PFL-induction chemotherapy followed by concomitant cisplatin chemoradiotherapy...
